SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Juan Li, Beihui Huang, Ying Li, Dong Zheng, Zhenhai Zhou, Junru Liu, Hepatitis B virus reactivation in patients with multiple myeloma receiving bortezomib-containing regimens followed by autologous stem cell transplant, Leukemia & Lymphoma, 2015, 1

    CrossRef

  2. 2
    Hong Li, Hong-min Zhang, Li-fen Chen, Ya-qin Chen, Ling Chen, Hong Ren, Huai-dong Hu, Prophylactic lamivudine to improve the outcome of HBsAg-positive lymphoma patients during chemotherapy: A systematic review and meta-analysis, Clinics and Research in Hepatology and Gastroenterology, 2015, 39, 1, 80

    CrossRef

  3. 3
    Sung-Nan Pei, Chien-Hung Chen, Risk and prophylaxis strategy of hepatitis B virus reactivation in patients with lymphoma undergoing chemotherapy with or without rituximab, Leukemia & Lymphoma, 2015, 1

    CrossRef

  4. 4
    Jun-Ying Liu, Yun-Jian Sheng, Xiang-Chun Ding, Hui Tang, Shi-Wen Tong, Da-Zhi Zhang, Zhi Zhou, Peng Hu, Yong Liao, Hong Ren, Huai-Dong Hu, The efficacy of lamivudine prophylaxis against hepatitis B reactivation in breast cancer patients undergoing chemotherapy: A meta-analysis, Journal of the Formosan Medical Association, 2015, 114, 2, 164

    CrossRef

  5. 5
    Mar Riveiro-Barciela, María Buti, Virus de la hepatitis B en el embarazo y el paciente inmunosuprimido, Gastroenterología y Hepatología, 2015, 38, 1, 31

    CrossRef

  6. 6
    Gui-Nan Lin, Jie-Wen Peng, Jian-jun Xiao, Dong-Ying Liu, Zhong-Jun Xia, Hepatitis B virus reactivation in hepatitis B surface antigen seropositive patients with metastatic non-small cell lung cancer receiving cytotoxic chemotherapy: the efficacy of preemptive lamivudine and identification of risk factors, Medical Oncology, 2014, 31, 8

    CrossRef

  7. 7
    Gang Huang, Wan Yee Lau, Feng Shen, Ze-ya Pan, Si-yuan Fu, Yun Yang, Wei-ping Zhou, Meng-chao Wu, Preoperative Hepatitis B Virus DNA Level is a Risk Factor for Postoperative Liver Failure in Patients Who Underwent Partial Hepatectomy for Hepatitis B-Related Hepatocellular Carcinoma, World Journal of Surgery, 2014, 38, 9, 2370

    CrossRef

  8. 8
    Mario Mandalà, Stefano Fagiuoli, Daniela Francisci, Raffaele Bruno, Barbara Merelli, Luisa Pasulo, Carlo Tondini, Roberto Labianca, Fausto Roila, Hepatitis B in immunosuppressed cancer patients: Pathogenesis, incidence and prophylaxis, Critical Reviews in Oncology/Hematology, 2013, 87, 1, 12

    CrossRef

  9. 9
    Chun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao, Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management, Hepatology International, 2013, 7, 2, 316

    CrossRef

  10. 10
    W H Y Ling, P P Soe, A S L Pang, S-C Lee, Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours, British Journal of Cancer, 2013, 108, 10, 1931

    CrossRef

  11. 11
    Tsutomu Nishida, Naoki Hiramatsu, Masao Mizuki, Izumi Nagatomo, Hiroshi Kida, Keiko Tazumi, Shinichiro Shinzaki, Masanori Miyazaki, Takayuki Yakushijin, Tomohide Tatsumi, Hideki Iijima, Shinichi Kiso, Tatsuya Kanto, Masahiko Tsujii, Tetsuo Takehara, Managing hepatitis B virus carriers with systemic chemotherapy or biologic therapy in the outpatient clinic, Hepatology Research, 2013, 43, 4
  12. 12
    Gang Huang, Eric C. H. Lai, Wan Yee Lau, Wei-ping Zhou, Feng Shen, Ze-ya Pan, Si-yuan Fu, Meng-chao Wu, Posthepatectomy HBV Reactivation in Hepatitis B–Related Hepatocellular Carcinoma Influences Postoperative Survival in Patients With Preoperative Low HBV-DNA Levels, Annals of Surgery, 2013, 257, 3, 490

    CrossRef

  13. 13
    M. Ikeda, Reactivation of Hepatitis B Virus in Patients Receiving Chemotherapy, Japanese Journal of Clinical Oncology, 2013, 43, 1, 8

    CrossRef

  14. 14
    Jessica P. Hwang, John M. Vierling, Andrew D. Zelenetz, Susan C. Lackey, Rohit Loomba, Hepatitis B virus management to prevent reactivation after chemotherapy: a review, Supportive Care in Cancer, 2012, 20, 11, 2999

    CrossRef

  15. 15
    Jeong Won Jang, Management of Patients with Hepatitis B Virus Infection Who Receive Immunosuppressive Treatment or Chemotherapy, Korean Journal of Medicine, 2012, 82, 2, 149

    CrossRef

  16. 16
    Matthew Schlumbrecht, Kevin Grimes, Jubilee Brown, Cytomegalovirus reactivation following chemoradiation for invasive cervical carcinoma, Gynecologic Oncology Case Reports, 2011, 1, 1, 22

    CrossRef

  17. 17
    Ramazan Idilman, Mutlu Arat, Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation, Expert Review of Anti-infective Therapy, 2011, 9, 8, 641

    CrossRef

  18. 18
    Zhengang Sun, Gaopeng Li, Xi Ai, Baoming Luo, Yanling Wen, Zizhuo Zhao, Shengli Dong, Jian Guan, Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: Incidence, diagnosis, treatment, outcome and mechanism, Critical Reviews in Oncology/Hematology, 2011, 79, 2, 164

    CrossRef

  19. 19
    Shih-Hung Tsai, Ming-Shen Dai, Jyh-Cherng Yu, Ching-Liang Ho, Yeu-Chin Chen, Yi-Ying Wu, Ping-Ying Chang, Woei-Yau Kao, Tsu-Yi Chao, Preventing chemotherapy-induced hepatitis B reactivation in breast cancer patients: a prospective comparison of prophylactic versus deferred preemptive lamivudine, Supportive Care in Cancer, 2011, 19, 11, 1779

    CrossRef

  20. 20
    Kavitha Gopal, Albert D. Min, Chemoprevention of Patients with Hepatitis B Receiving Chemotherapy or Bone Marrow Transplant, Current Hepatitis Reports, 2010, 9, 3, 178

    CrossRef

  21. You have free access to this content21
    John S Lubel, Peter W Angus, Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management, Journal of Gastroenterology and Hepatology, 2010, 25, 5
  22. 22
    Münci Yağcı, Zübeyde Nur Özkurt, Zeynep Arzu Yeğin, Zeynep Akı, Gülsan Türköz Sucak, Rauf Haznedar, Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies, Hematology, 2010, 15, 4, 240

    CrossRef

  23. 23
    Winnie Yeo, Hepatitis B virus reactivation in association with antineoplastic therapy, Current Hepatitis Reports, 2009, 8, 3, 127

    CrossRef

  24. 24
    Anthony Post, Shweta Nagendra, Reactivation of hepatitis B: Pathogenesis and clinical implications, Current Infectious Disease Reports, 2009, 11, 2, 113

    CrossRef

  25. 25
    Mayra J. Sanchez, Maria Buti, Maria Homs, Andres Palacios, Francisco Rodriguez-Frias, Rafael Esteban, Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab, Journal of Hepatology, 2009, 51, 6, 1091

    CrossRef

  26. 26
    George K. K. Lau, Hepatitis B reactivation after chemotherapy: two decades of clinical research, Hepatology International, 2008, 2, 2, 152

    CrossRef

  27. 27
    L. H. Katz, A. Fraser, A. Gafter-Gvili, L. Leibovici, R. Tur-Kaspa, Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis, Journal of Viral Hepatitis, 2008, 15, 2
  28. 28
    Lenna A. Martyak, Ehsan Taqavi, Sammy Saab, Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis, Liver International, 2008, 28, 1
  29. 29
    Roberto J. Firpi, David R. Nelson, Management of viral hepatitis in hematologic malignancies, Blood Reviews, 2008, 22, 3, 117

    CrossRef

  30. 30
    Masami Miyagawa, Masahito Minami, Kota Fujii, Rei Sendo, Kojiro Mori, Daisuke Shimizu, Tomoaki Nakajima, Kohichiroh Yasui, Yoshito Itoh, Masafumi Taniwaki, Takeshi Okanoue, Toshikazu Yoshikawa, Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab, Journal of Medical Virology, 2008, 80, 12
  31. 31
    Ali Amouri, Lassaad Chtourou, Leila Mnif, Nabi Tahri, Prise en charge de la réactivation virale B au cours d’un traitement chimiothérapique ou immunosuppresseur, La Presse Médicale, 2008, 37, 11, 1591

    CrossRef

  32. 32
    Holbrook E. Kohrt, Daniel L. Ouyang, Emmet B. Keeffe, Antiviral Prophylaxis for Chemotherapy-Induced Reactivation of Chronic Hepatitis B Virus Infection, Clinics in Liver Disease, 2007, 11, 4, 965

    CrossRef

  33. 33
    Min Kyoung Kim, Jin Hee Ahn, Sung-Bae Kim, Young-Suk Im, Soon Im Lee, Sei-Hyun Ahn, Byung Ho Son, Gyungyub Gong, Hak-Hee Kim, Woo Kun Kim, Hepatitis B Reactivation During Adjuvant Anthracycline-Based Chemotherapy in Patients with Breast Cancer: A Single Institution's Experience, The Korean Journal of Internal Medicine, 2007, 22, 4, 237

    CrossRef

  34. 34
    Ji Hoon Kim, Joong-Won Park, Tae Hyun Kim, Dong Wook Koh, Woo Jin Lee, Chang-Min Kim, Hepatitis B Virus Reactivation After Three-Dimensional Conformal Radiotherapy in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma, International Journal of Radiation Oncology*Biology*Physics, 2007, 69, 3, 813

    CrossRef

  35. 35
    J. S. Lubel, A. G. Testro, P. W. Angus, Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management, Internal Medicine Journal, 2007, 37, 10
  36. 36
    Jin Seok Kim, Jee Sook Hahn, Sun Young Park, Yuri Kim, In Hae Park, Chun Kyon Lee, June-Won Cheong, Seung Tae Lee, Yoo Hong Min, Long-term Outcome after Prophylactic Lamivudine Treatment on Hepatitis B Virus Reactivation in Non-Hodgkin's Lymphoma, Yonsei Medical Journal, 2007, 48, 1, 78

    CrossRef

  37. 37
    Gadi Lalazar, Deborah Rund, Daniel Shouval, Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies, British Journal of Haematology, 2007, 136, 5
  38. 38
    Jeong Won Jang, Jong Young Choi, Si Hyun Bae, Seung Kew Yoon, U Im Chang, Chang Wook Kim, Se Hyun Cho, Jun Yeol Han, Young Sok Lee, A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization, Hepatology, 2006, 43, 2
  39. 39
    F. Watzinger, K. Ebner, T. Lion, Detection and monitoring of virus infections by real-time PCR, Molecular Aspects of Medicine, 2006, 27, 2-3, 254

    CrossRef

  40. 40
    Winnie Yeo, Philip J. Johnson, Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy, Hepatology, 2006, 43, 2
  41. 41
    Katherine Thornton, Postprocedure Clinical Management for the Interventional Radiologist, Techniques in Vascular and Interventional Radiology, 2006, 9, 3, 106

    CrossRef

  42. 42
    Feng-Chiao Tsai, Song-Chou Hsieh, Ding-Shinn Chen, Jin-Chuan Sheu, Ding-Shinn Chen, Reactivation of Hepatitis B Virus in Rheumatologic Patients Receiving Immunosuppressive Agents, Digestive Diseases and Sciences, 2006, 51, 9, 1627

    CrossRef

  43. 43
    H. E. KOHRT, D. L. OUYANG, E. B. KEEFFE, Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection, Alimentary Pharmacology & Therapeutics, 2006, 24, 7
  44. 44
    Ming-Shen Dai, Tsu-Yi Chao, Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive?, Breast Cancer Research and Treatment, 2005, 92, 1, 95

    CrossRef

  45. 45
    Swan-Swan Leong, Joseph Wee, Miah Hiang Tay, Chee Keong Toh, Say Beng Tan, Choon Hua Thng, Kian Fong Foo, Wan Teck Lim, Terence Tan, Eng Huat Tan, Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma, Cancer, 2005, 103, 3
  46. 46
    Marc Bourlière, Portage inactif du virus de l’hépatite B, Gastroentérologie Clinique et Biologique, 2005, 29, 4, 369

    CrossRef

  47. 47
    M. S. Dai, P. F. Wu, R. Y. Shyu, J. J. Lu, T. Y. Chao, Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration, Liver International, 2004, 24, 6
  48. 48
    CHEE-KIN HUI, WING-YAN AU, GEORGE K K LAU, Preemptive therapy for hepatitis B patients undergoing chemotherapy, Journal of Gastroenterology and Hepatology, 2004, 19,
  49. 49
    Lior H Katz, Abigail Fraser, Leonard Leibovici, Rani Tur-Kaspa, Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapy, The Cochrane Library,
  50. 50
    Lior H Katz, Abigail Fraser, Leonard Leibovici, Rani Tur-Kaspa, Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapy, The Cochrane Library,